Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of intermittent oral vs semi-continuous intra-oral levodopa/carbidopa in advanced Parkinson's disease with motor fluctuations
2014-002295-87Phase 2Completed
- Sponsor
- SynAgile
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by SynAgile. Primary endpoint: Variability in plasma levodopa/carbidopa pharmacokinetics. Started Sep 2014; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2014-002295-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002295-87.